Kantonsspital St.Gallen

Arimoclomol in Amyotropic Lateral Sclerosis

Christoph Neuwirth

abstract A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of arimoclomol in amyotropic lateral sclerosis (ALS)
type of project clinical studies
status aborted
start of project 2018
end of project 2020
responsible person Neuwirth, Christoph